Neuronetics, Inc. has made an important update regarding its stock transactions, correcting details from a previous filing. This update is significant as it reflects the company's ongoing activities and transparency in the surgical and medical instruments industry.
The recent filing, dated November 19, 2026, serves to amend a prior submission made on November 18, 2026. The correction clarifies that Glenn P. Muir, a director at Neuronetics, purchased 175,000 shares of common stock at an average price of $1.31 per share on November 16, 2026. The filing states, "This Form 4 is therefore being filed to correct the footnote to refer to a purchase," highlighting the importance of accurate reporting in financial disclosures.
Neuronetics, Inc. is categorized under the SIC code 3841, which encompasses companies involved in surgical and medical instruments and apparatus. The firm trades on the Nasdaq under the ticker symbol STIM. As an operating company, Neuronetics focuses on developing innovative solutions in the medical field, particularly in neurostimulation.
In the amended filing, Muir's post-transaction ownership stands at 576,816 shares. The correction provides clarity on Muir's investment activities, which may influence investor sentiment and market behavior surrounding Neuronetics' stock. The company has been active in filing various reports recently, including multiple Form 4 submissions and a Schedule 13D/A, indicating ongoing engagement with its shareholders and the market.
This correction may have implications for other stakeholders, including investors and analysts, who track Neuronetics' activities closely. The surgical and medical instruments sector is competitive, and companies within this space often monitor each other's movements to assess market positioning.
Looking ahead, further filings may provide additional insights into Neuronetics' financial health and strategic direction. However, the filing does not specify what actions will follow this correction.
Read Next
Clark Kyle Sells 15,000 Shares of Beta Technologies Stock
Ronald R. Taylor resigns as director of ResMed Inc.
Afsari Nasym acquires 68,235 shares of Onterris, Inc.
Onterris, Inc. Chief Strategy Officer Acquires Shares
StubHub Holdings' Mark Streams Sells 76,891 Shares
Francesca M. Edwardson Transfers 25,000 Shares to Trust




